Oracle CEO Clayton Magouyrk gets 446K-unit stock grant
Vesting runs from October 15, 2027, through October 15, 2031, subject to continued employment through each applicable vesting date.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Oracle Corp. Chief Executive Officer Clayton M. Magouyrk received an award of 446,197 restricted stock units on October 15, 2026; the reported resulting position was 446,197 units. Each unit represents the right to receive one common share at settlement. The units vest 40% on October 15, 2027, 30% on October 15, 2028, 20% on October 15, 2029, 5% on October 15, 2030, and 5% on October 15, 2031, subject to continued employment through each applicable vesting date.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Unit F1, F2 | 446,197 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F2. The shares subject to the restricted stock units will vest as to 40% on October 15, 2027, 30% on October 15, 2028, 20% on October 15, 2029, 5% on October 15, 2030 and 5% on October 15, 2031, subject to the Reporting Person's continued employment through each applicable vesting date
Key Figures
Key Terms
restricted stock unit financial
settlement financial
vesting date financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many restricted stock units did ORCL CEO Clayton M. Magouyrk receive?
When do Clayton M. Magouyrk's ORCL restricted stock units vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.